Akari Therapeutics PLC (AKTX)
1.24
-0.23
(-15.65%)
USD |
NASDAQ |
Nov 21, 16:00
1.28
+0.04
(+3.23%)
After-Hours: 20:00
Akari Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 0.3579 |
| Adaptimmune Therapeutics PLC | 0.6234 |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.734M |
| Total Liabilities (Quarterly) | 9.428M |
| Shareholders Equity (Quarterly) | -6.694M |